Overview

Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Memantine hydrochloride may help people stop smoking by decreasing the symptoms of nicotine withdrawal. PURPOSE: This randomized, pilot phase II trial studies how effective memantine hydrochloride works compared to placebo in helping cancer survivors stop smoking.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest University Health Sciences
Collaborator:
National Cancer Institute (NCI)
Treatments:
Memantine